Literature DB >> 3861846

Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs.

M Sekine, H Terashima, K Sasahara, K Nishimura, R Okada, S Awazu.   

Abstract

The effect of medium chain glyceride (MCG) on the intestinal absorption of cefmetazole sodium (CMZ) was investigated in rats and dogs. In rats, MCG containing glyceryl mono-, di- and tri-caprylate enhanced the intestinal absorption of CMZ after intraduodenal administration, though the promoting effect of MCG was less than that after rectal administration. The promoting effect of MCG was found to be mainly due to glycerylmonocaprylate and dependent on the dosage of MCG. The plasma CMZ levels after intraduodenal administration as MCG solution tended to be slightly higher than those observed after administration as MCG emulsion, though the differences were found to be statistically insignificant. Moreover, the intestinal absorption of CMZ after intraduodenal administration as MCG emulsion was decreased significantly by increasing the amount of water in the emulsion. The promoting effect of MCG in dogs was more clearly demonstrated in the lower intestine than in the upper intestine. Furthermore, the oral bioavailability of pharmaceutical formulations of CMZ was also investigated in dogs. When enteric coated capsules filled with MCG solution were administered to dogs, the bioavailability of CMZ was enhanced significantly.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861846     DOI: 10.1248/bpb1978.8.286

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  5 in total

1.  Effect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitro.

Authors:  P Y Yeh; P L Smith; H Ellens
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

2.  Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation.

Authors:  K Oka; Y Miyamoto; Y Matsumura; S Tanaka; T Oda; F Suzuki; H Maeda
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

3.  Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.

Authors:  E J Van Hoogdalem; A T Wackwitz; A G De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

4.  Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog.

Authors:  S C Sutton; E L LeCluyse; K Engle; J D Pipkin; J A Fix
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

Review 5.  Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.

Authors:  P P Constantinides
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.